caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1871508937

Semyon GambarinMD

General SurgeryAustin, TXI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
34
Beneficiaries
—
Total drug cost
$575
Distinct drugs
1
Brand share
100.0%
Top prescribed drugs
Peg3350/Sod Sulf,bicarb,cl/Kcl18 claims
Peg3350/Sod Sulf,bicarb,cl/Kcl16 claims
REFERRAL NETWORK

Where Semyon Gambarin's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
AUSTIN CENTER FOR OUTPATIENT SURGERY LP4083
Clinical Pathology Laboratories, Inc.
Clinical Laboratory · Austin, TX
3162
ASCENSION SETON3059
ASCENSION SETON2749
James Hull
Internal Medicine · Austin, TX
1549
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
378
Unique beneficiaries
—
Total services
383
Distinct HCPCS
12
Medicare payment
$40K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 1,477 General Surgery providers in TX — top quintile (cohort median 212).